4//SEC Filing
BOLGER JOHN C 4
Accession 0001209191-22-015590
CIK 0001674930other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:01 PM ET
Size
20.3 KB
Accession
0001209191-22-015590
Insider Transaction Report
Form 4
BOLGER JOHN C
Director
Transactions
- Sale
Common Stock
2022-03-01$61.42/sh−625$38,388→ 2,000 total - Sale
Common Stock
2022-03-01$61.40/sh−625$38,376→ 2,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-01−625→ 2,813 totalExercise: $15.82Exp: 2030-05-26→ Common Stock (625 underlying) - Exercise/Conversion
Common Stock
2022-03-01$3.92/sh+625$2,453→ 2,625 total - Sale
Common Stock
2022-03-01$61.27/sh−625$38,293→ 2,000 total - Exercise/Conversion
Common Stock
2022-03-01$5.81/sh+625$3,631→ 2,625 total - Exercise/Conversion
Common Stock
2022-03-01$15.82/sh+625$9,888→ 2,625 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-01−625→ 313 totalExercise: $3.92Exp: 2028-05-18→ Common Stock (625 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-01−625→ 1,563 totalExercise: $5.81Exp: 2029-05-30→ Common Stock (625 underlying)
Footnotes (4)
- [F1]The shares were sold in multiple transactions at prices ranging from $61.0767 to $61.4400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F2]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
- [F3]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
- [F4]The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
Documents
Issuer
Fulgent Genetics, Inc.
CIK 0001674930
Entity typeother
Related Parties
1- filerCIK 0001183863
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:01 PM ET
- Size
- 20.3 KB